WallStSmart
MRVI

Maravai Lifesciences Holdings Inc

NASDAQ: MRVI · HEALTHCARE · BIOTECHNOLOGY

$3.68
+5.75% today

Updated 2026-04-30

Market cap
$542.79M
P/E ratio
P/S ratio
2.92x
EPS (TTM)
$-0.90
Dividend yield
52W range
$2 – $4
Volume
1.8M

Maravai Lifesciences Holdings Inc (MRVI) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20182019202020212022202320242025
Revenue$123.83M$143.14M$284.10M$799.24M$883.00M$288.94M$259.19M$185.74M
Revenue growth (YoY)+15.6%+98.5%+181.3%+10.5%-67.3%-10.3%-28.3%
Cost of revenue$60.77M$66.85M$79.65M$140.56M$168.96M$148.74M$150.88M$152.35M
Gross profit$63.07M$76.29M$204.45M$658.68M$714.04M$140.20M$108.31M$33.39M
Gross margin50.9%53.3%72.0%82.4%80.9%48.5%41.8%18.0%
R&D$4.50M$3.63M$9.30M$15.22M$18.37M$17.28M$19.22M$23.33M
SG&A$41.19M$48.35M$94.25M$100.06M$129.26M$150.12M$161.77M$145.12M
Operating income$16.44M$23.99M$119.90M$554.64M$574.22M$-31.65M$-235.62M$-6.74M
Operating margin13.3%16.8%42.2%69.4%65.0%-11.0%-90.9%-3.6%
EBITDA$33.25M$48.19M$138.27M$585.78M$609.99M$712.41M$-156.92M$-147.11M
EBITDA margin26.8%33.7%48.7%73.3%69.1%246.6%-60.5%-79.2%
EBIT$10.90M$24.11M$112.44M$561.02M$571.89M$663.63M$-213.78M$-207.98M
Interest expense$27.40M$29.96M$30.74M$30.26M$20.41M$45.89M$47.70M$26.99M
Income tax$417000.00$-652000.00$2.88M$61.52M$60.81M$756.11M$-1.86M
Effective tax rate-2.4%7.1%3.6%25.3%21.6%118.7%1.3%0.0%
Net income$-17.73M$-8.49M$76.89M$182.04M$220.21M$-119.03M$-144.85M$-130.77M
Net income growth (YoY)+52.1%+1006.1%+136.8%+21.0%-154.1%-21.7%+9.7%
Profit margin-14.3%-5.9%27.1%22.8%24.9%-41.2%-55.9%-70.4%